NCT07546188 AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.
| NCT ID | NCT07546188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Grand Hôpital de Charleroi |
| Condition | Lymphoma, Non-Hodgkin |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2026-02-15 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2026-02-15 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research forms part of a continuous quality improvement initiative. It aims to assess patient compliance of oral therapies by artificial intelligence. It could overcome the limitations of current practices and enhance the responsiveness and accuracy of clinical interventions.
Eligibility Criteria
Inclusion Criteria: * All patients aged 18 and over who are treated in the Haematology Department at the Grand Hôpital de Charleroi from November 2025 onwards * Treated for a lymphoma, Non Hodgkin * Capable of giving informed consent Exclusion Criteria: * All other patients who did not meet the eligibility criteria
Contact & Investigator
Marie Detrait, MD, PhD
PRINCIPAL INVESTIGATOR
Grand Hôpital de Charleroi
Frequently Asked Questions
Who can join the NCT07546188 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lymphoma, Non-Hodgkin. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07546188 currently recruiting?
Yes, NCT07546188 is actively recruiting participants. Contact the research team at marie.detrait@ghdc.be for enrollment information.
Where is the NCT07546188 trial being conducted?
This trial is being conducted at Charleroi, Belgium.
Who is sponsoring the NCT07546188 clinical trial?
NCT07546188 is sponsored by Grand Hôpital de Charleroi. The principal investigator is Marie Detrait, MD, PhD at Grand Hôpital de Charleroi. The trial plans to enroll 210 participants.